脑肠同调理论与胃食管反流病诊疗理念

魏玮; 王倩影

doi:10.3969/j.issn.1671-038X.2023.07.05

脑肠同调理论与胃食管反流病诊疗理念

魏玮^1,2,3, ,,
王倩影^1,4

- 1.
  中国中医科学院望京医院脾胃病科 (北京，100102)
- 2.
  功能性胃肠病中医诊治北京市重点研究室(BZ0374)
- 3.
  国家中医药管理局“脑肠同调治则治法”重点研究室
- 4.
  天津中医药大学
基金项目:
中医药防治消化道癌前疾病传承与创新团队(No: ZYYCXTD-C-202210);中医药传承与创新“百千万”人才工程(岐黄工程)岐黄学者项目(No: GJZYY-2019-QHXZ)

详细信息

作者简介:
魏玮，博士生导师，博士后合作导师。师承国医大师路志正教授。“国家百千万人才工程”国家级人选、国家有突出贡献中青年专家、首届国家中医药领军人才工程“岐黄学者”、国家中医药传承与创新团队(中医药防治消化道癌前疾病)带头人、国家中医药管理局“脑肠同调治则治法”重点研究室主任、国务院特殊津贴专家。现任中国中医科学院首席研究员、首都名中医、中国中医科学院望京医院脾胃病科科主任。功能性胃肠病中医诊治北京市重点实验室主任。国家中西医结合临床重点学科、国家临床重点专科学术带头人。社会兼职：中国中西医结合学会消化内镜学专业委员会主任委员，中国中医药研究促进会消化整合医学分会会长，中华中医药学会第五、六届理事会理事，第一届监事会监事，欧美同学会医师协会第一届理事会理事等。主持包括国家自然科学基金国际合作重点项目、国家自然科学基金区域联合重点项目、科技部中医药行业专项项目、国家科技支撑计划“十二五”项目等国家科研项目10余项。临床擅长胃食管反流病、功能性胃肠病、慢性萎缩性胃炎、疑难消化系统疾病的诊疗

通讯作者: 魏玮，E-mail：sxxtyy@sina.com

中图分类号: R473.5

收稿日期: 2023-04-12

刊出日期: 2023-07-15

Brain-Gut Co-regulation theory and gastroesophageal reflux disease diagnosis and treatment concept

WEI Wei^1,2,3, ,,
WANG Qianying^1,4

- 1.
  Department of Gastroenterology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, China
- 2.
  Laboratory of Functional Gastrointestinal Disorders Diagnosis and Treatment of Traditional Chinese Medicine(BZ0374)
- 3.
  The State Administration of Traditional Chinese Medicine "Brain-Gut Co-regulation Adjustment and Treatment" Key Research Department
- 4.
  Tianjin University of Traditional Chinese Medicine

More Information

Corresponding author: WEI Wei, E-mail: sxxtyy@sina.com

Received Date: 12 April 2023

Publish Date: 15 July 2023

摘要

摘要: 胃食管反流病因与患者生活方式及精神心理因素密切相关，又多与功能性胃肠病症状重叠，“难治”特点突出。治疗上以抑酸为主，随着抑酸药使用的增多，胃底腺息肉增生、骨质疏松、肠道菌群紊乱等不良反应逐渐暴露。笔者传承国医大师路志正先生的学术经验，结合临床实践，创新提出“脑肠同调”理论，与胃食管反流病的诊疗理念不谋而合，可为胃食管反流病的诊疗困境提供突破点。
- 胃食管反流病 /
- 脑肠同调理论 /
- 诊疗理念 /
- 中西医结合
Abstract: Because gastroesophageal reflux disease is closely related to the patient's lifestyle and psychological factors, and often overlaps with functional gastrointestinal symptoms, the "refractory" feature is prominent. Treatment is mainly to inhibit gastric acid, and with the increase in the use of acid inhibitor, side effects such as fundic polyp hyperplasia, osteoporosis, and intestinal flora disorders are gradually exposed. The author inherits the academic experience of LU Zhizheng, a master of Traditional Chinese Medicine, combines clinical practice, and innovatively puts forward the theory of "Brain-Gut Co-regulation", which coincides with the diagnosis and treatment concept of gastroesophageal reflux disease and can provide a breakthrough point for the diagnosis and treatment of gastroesophageal reflux disease.
- gastroesophageal reflux disease /
- Brain-Gut Co-regulation theory /
- diagnosis and treatment concept /
- integrated Traditional Chinese and Western Medicine

HTML全文

参考文献(33)

[1]	Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus[J]. Am J Gastroenterol, 2006, 101(8): 1900-1920. doi: 10.1111/j.1572-0241.2006.00630.x
[2]	Eusebi LH, Ratnakumaran R, Yuan YH, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis[J]. Gut, 2018, 67(3): 430-440. doi: 10.1136/gutjnl-2016-313589
[3]	中华医学会消化病学分会. 2020年中国胃食管反流病专家共识[J]. 中华消化杂志, 2020, 40(10): 649-663. doi: 10.3760/cma.j.cn311367-20200918-00558
[4]	中国医疗保健国际交流促进会胃食管反流病学分会. 中国胃食管反流病多学科诊疗共识2022[J/OL]. 中华胃食管反流病电子杂志, 2022, 9(2): 51-120.
[5]	独思静, 毛心勇, 刘倩, 等. "脑肠同调"治法在常见脾胃病中的运用[J]. 新中医, 2021, 53(2): 211-214. https://www.cnki.com.cn/Article/CJFDTOTAL-REND202102056.htm
[6]	侯理伟, 苏晓兰, 郭宇, 等. 胃不和则卧不安——魏玮教授从脾胃论治失眠的学术思想[J]. 中国中西医结合消化杂志, 2018, 26(9): 791-793. http://zxpw.cbpt.cnki.net/WKD2/WebPublication/paperDigest.aspx?paperID=e3d3654c-c497-4eaa-92e9-8a9da870a197
[7]	王笑语, 张启明, 王义国. "胃不和则卧不安"的生物学基础[J]. 中医药学报, 2021, 49(12): 1-4. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXB202112001.htm
[8]	魏玮, 荣培晶, 陈建德, 等. "调枢通胃"理论的探讨与构建[J]. 中医杂志, 2018, 59(6): 474-477, 502. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201806007.htm
[9]	Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2022, 117(1): 27-56. doi: 10.14309/ajg.0000000000001538
[10]	崔玉容, 国嵩, 刘倩, 等. 基于"滞、郁、瘀、虚"疾病观论治胃食管反流病[J]. 中国中西医结合消化杂志, 2022, 30(3): 236-239. http://zxpw.cbpt.cnki.net/WKD2/WebPublication/paperDigest.aspx?paperID=a6252022-8fb1-4173-a836-112764b64344
[11]	方霜霜, 潘雨烟, 独思静, 等. 基于"郁、虚、滞、瘀"四因致病论治难治性胃食管反流病[J]. 长春中医药大学学报, 2021, 37(5): 996-999. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX202105015.htm
[12]	Ang D, How CH, Ang TL. Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy[J]. Singapore Med J, 2016, 57(10): 546-551. doi: 10.11622/smedj.2016167
[13]	Abrahami D, McDonald EG, Schnitzer ME, et al. Proton pump inhibitors and risk of gastric cancer: population-based cohort study[J]. Gut, 2022, 71(1): 16-24. doi: 10.1136/gutjnl-2021-325097
[14]	Perry IE, Sonu I, Scarpignato C, et al. Potential proton pump inhibitor-related adverse effects[J]. Ann NY Acad Sci, 2020, 1481(1): 43-58. doi: 10.1111/nyas.14428
[15]	Choi JM, Yang JI, Kang SJ, et al. Association between anxiety and depression and gastroesophageal reflux disease: results from a large cross-sectional study[J]. J Neurogastroenterol Motil, 2018, 24(4): 593-602. doi: 10.5056/jnm18069
[16]	Zeng YJ, Cao S, Yang H. The causal role of gastroesophageal reflux disease in anxiety disorders and depression: a bidirectional Mendelian randomization study[J]. Front Psychiatry, 2023, 14: 1135923. doi: 10.3389/fpsyt.2023.1135923
[17]	Lim KG, Morgenthaler TI, Katzka DA. Sleep and nocturnal gastroesophageal reflux[J]. Chest, 2018, 154(4): 963-971. doi: 10.1016/j.chest.2018.05.030
[18]	Wong MW, Liu TT, Yi CH, et al. Oesophageal hypervigilance and visceral anxiety relate to reflux symptom severity and psychological distress but not to acid reflux parameters[J]. Aliment Pharmacol Ther, 2021, 54(7): 923-930. doi: 10.1111/apt.16561
[19]	Losa M, Manz SM, Schindler V, et al. Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non-erosive reflux disease[J]. Neurogastroenterol Motil, 2021, 33(9): e14177.
[20]	Vakil N, Stelwagon M, Shea EP, et al. Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population[J]. United European Gastroenterol J, 2016, 4(3): 413-422. doi: 10.1177/2050640615600114
[21]	Xiao YL, Peng S, Tao J, et al. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome criteria[J]. Am J Gastroenterol, 2010, 105(12): 2626-2631. doi: 10.1038/ajg.2010.351
[22]	de Bortoli N. Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome[J]. World J Gastroenterol, 2013, 19(35): 5787. doi: 10.3748/wjg.v19.i35.5787
[23]	Quigley EMM, Lacy BE. Overlap of functional dyspepsia and GERD-diagnostic and treatment implications[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(3): 175-186. doi: 10.1038/nrgastro.2012.253
[24]	Lee SW, Chang CS. Impact of overlapping functional gastrointestinal disorders on the quality of life in patients with gastroesophageal reflux disease[J]. J Neurogastroenterol Motil, 2021, 27(2): 176-184. doi: 10.5056/jnm19006
[25]	Ness-Jensen E, Hveem K, El-Serag H, et al. Lifestyle intervention in gastroesophageal reflux disease[J]. Clin Gastroenterol Hepatol, 2016, 14(2): 175-182. doi: 10.1016/j.cgh.2015.04.176
[26]	Yuan S, Larsson SC. Adiposity, diabetes, lifestyle factors and risk of gastroesophageal reflux disease: a Mendelian randomization study[J]. Eur J Epidemiol, 2022, 37(7): 747-754. doi: 10.1007/s10654-022-00842-z
[27]	Taraszewska A. Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet[J]. Rocz Panstw Zakl Hig, 2021, 72(1): 21-28.
[28]	Esmaillzadeh A, Keshteli AH, Feizi A, et al. Patterns of diet-related practices and prevalence of gastroesophageal reflux disease[J]. Neurogastroenterol Motil, 2013, 25(10): 831-e638.
[29]	Kessing BF, Bredenoord AJ, Saleh CMG, et al. Effects of anxiety and depression in patients with gastroesophageal reflux disease[J]. Clin Gastroenterol Hepatol, 2015, 13(6): 1089-1095.e1. doi: 10.1016/j.cgh.2014.11.034
[30]	Fujiwara Y, Arakawa T, Fass R. Gastroesophageal reflux disease and sleep disturbances[J]. J Gastroenterol, 2012, 47(7): 760-769. doi: 10.1007/s00535-012-0601-4
[31]	Jansson C, Nordenstedt H, Wallander MA, et al. A population-based study showing an association between gastroesophageal reflux disease and sleep problems[J]. Clin Gastroenterol Hepatol, 2009, 7(9): 960-965. doi: 10.1016/j.cgh.2009.03.007
[32]	Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease[J]. BMJ, 2020, 371: m3786.
[33]	Fass R, Thomas S, Traxler B, et al. Patient reported outcome of heartburn improvement: Doubling the proton pump inhibitor(PPI)dose in patients who failed standard dose PPI versus switching to a different PPI[J]. Gastroenterology, 2004, 146: A37.